Aims and objectives

The ESCMID Study Group for Host and Microbiota Interactions (ESGHAMI) is leading the way in bridging diagnostics, clinical research, and scientific studies across the relatively new field of microbiota research in Europe. The group seeks to understand the clinical significance of host-microbiota associated diseases and health, and explore relevant therapeutic interventions. Their research covers:

  • Intestinal, urogenital, respiratory, and skin microbiota of both humans and animals
  • Interactions of microbiota with the host immune response

Activities and resources

ESGHAMI Newsletter, Spring 2024, April 2024

Download


ESGHAMI Newsletter, Spring 2023, April 2023

Download


ESGHAMI Newsletter, Spring 2023, May 2023

Download


ESGHAMI Newsletter, Summer 2023, June 2023

Download


ESGHAMI Newsletter, Summer 2023, September 2023

Download


ESGHAMI Newsletter, Winter 2023, December 2023

Download

Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.

van Prehn J, van Werkhoven CH, Skinner AM, Guery B, Dubberke ER, Kuijper EJ. Clinical Microbiology and Infection 2024;30(2):165–169.

Go to publication


Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.

van Prehn J, Fitzpatrick F, Kuijper EJ. Lancet Gastroenterol Hepatol. 2022;7(12):1083–1091.

Go to publication


Bacteriophage therapy in humans.

Nir-Paz R, Kuijper EJ. Clin Microbiol Infect. 2023;29(6):679–681.

Go to publication


Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023.

Benech N, Barbut N, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, hHeritage J, Guery B, Kuijper E. Clinical Microbiology and Infection. 2023:S1198-743X(23)00597-9.

Go to publication

Defining the Role of Malassezia in the Malignant Transformation of Pancreatic Cysts

03 December 2024, 16:00 - 16:45 CET

Programme: 

  • Prof. Dr. Ed Kuijper;  Introduction (5 min)   
  • Dr. Ruben Bellotti. The role of Malassezia in pancreatic cysts (30 min)
  • Prof. Ferry Hagen/prof. Ed Kuijper. General discussion (10 min )

Go to webinar


The urinary microbiome in health and disease : analysis of urine samples from 2,000 individuals in the swedish nation-wide SCAPIS cohort

23 October 2024, 16:00 - 17:00 CET

Join us for an insightful presentation by Tiscar Graells from the Karolinska Institute, who will share the latest findings from the Swedish nationwide cohort SCAPIS. Don't miss this opportunity to learn about cutting-edge research on the urobiome and its potential health implications!

Go to webinar


Update on Live biotherapeutic products and FMT-like treatments for recurrent Clostridioides difficile infections

21 June 2023

Go to webinar

Microbiome from benchtop to bedside technical workshop

Executive Committee

  Ed J. Kuijper

Ed J. Kuijper

Chair
Leiden University Medical Centre
Leiden, Netherlands
  Nicolas Benech

Nicolas Benech

Treasurer
Hospices Civils de Lyon
Lyon, France
  Silvia Corcione

Silvia Corcione

Secretary
University of Turin
Turin, Italy

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form